Saturday 17 October 2026
Export ENSC’s income statement to Excel — free account
Ensysce Biosciences, Inc.
ENSC Healthcare Biotechnology
Ensysce Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 million, down 2.75% from fiscal 2024. In the quarter to June 2026, revenue fell 15.1%, EPS grew 74.7% and free cash flow grew 27.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.52
0.08
−13.33%
Follow ENSC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
2 | 3 | 3 | 3 |
+8 more TTM periods Free account |
| (1,295.01%) | (1,149.06%) | (324.86%) | (294.39%) | ||
| (295.92%) | (347.70%) | (155.95%) | (174.66%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
1,136.46% | 1,658.44% | (363.24%) | (1,468.48%) | |
Average Days of Receivables |
33.80 | 0.00 | 30.28 | 0.36 | |
Free Cash Flow per Share |
(0.68) | (1.40) | (3.05) | (2.44) | |
Free Cash Flow |
(8.86) | (9.60) | (7.81) | (7.04) | |
| Other line items | |||||
Cash ROIC |
2,039.94% | (12,548.76%) | (108.49%) | (276.49%) | |
Accounts Receivable Turnover |
20.51 | 0.00 | 18.61 | 5.02 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
275.21% | 251.46% | 204.81% | 235.44% | |
Selling, General and Administrative Expense of Revenue |
106.11% | 99.94% | 97.32% | 110.45% | |
Share Based Compensation of Revenue |
(0.34%) | 3.60% | 3.50% | 4.07% | |
Interest Coverage |
(791.34) | (626.22) | (541.85) | (454.14) | |
Operating CF/Net income |
0.70 | 0.81 | 0.77 | 0.64 | |
Depreciation/Fixed assets |
0.18 | 0.11 | 0.26 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | — | |
Revenue per Share |
0.35 | 0.69 | 1.98 | 1.56 | |
Operating CF per Share |
(0.68) | (1.40) | (3.05) | (2.44) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates